Aridis Pharmaceuticals, Inc. (ARDS)

Aridis Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019	2018
Revenue	0	0	1	1.02	2.76
Revenue Growth (YoY)	-	-	-2.15%	-62.93%	220.58%
Gross Profit	0	0	1	1.02	2.76
Selling, General & Admin	7.16	7.31	6.45	6.03	3.87
Research & Development	25.92	37.94	16.96	24.08	23
Other Operating Expenses	-3.09	-1.54	0	0	0
Operating Expenses	29.99	43.71	23.4	30.11	26.87
Operating Income	-29.99	-43.71	-22.4	-29.09	-24.12
Interest Income	0	0	0.08	0.36	0
Interest Expense	0.38	-0.25	0	0	0.42
Other Expense / Income	-	-0.27	0.01	0.95	-4.86
Pretax Income	-30.37	-43.19	-22.33	-29.68	-22.11
Income Tax	0.38	-0.91	-0.41	-0.7	2.43
Net Income	-30.75	-42.28	-21.92	-28.99	-22.11
Shares Outstanding (Basic)	19	12	9	8	3
Shares Outstanding (Diluted)	19	12	9	8	3
Shares Change	52.77%	34.06%	8.40%	168.80%	-60.12%
EPS (Basic)	-1.64	-3.44	-2.39	-3.43	-7.02
EPS (Diluted)	-1.64	-3.44	-2.39	-3.43	-7.02
Free Cash Flow	-29.21	-23.47	-20.84	-8.33	-24.95
Free Cash Flow Per Share	-1.56	-1.91	-2.27	-0.99	-7.93
Gross Margin	-	-	100.00%	100.00%	100.00%
Operating Margin	-	-	-2240.10%	-2846.09%	-874.76%
Profit Margin	-	-	-2191.90%	-2836.20%	-801.78%
Free Cash Flow Margin	-	-	-2084.30%	-815.36%	-904.90%
EBITDA	-29.51	-44.43	-22.4	-29.09	-25.75
EBITDA Margin	-	-	-2240.10%	-2846.09%	-933.95%
Depreciation & Amortization	0.49	0.44	0.34	0.34	0.28
EBIT	-29.99	-44.87	-22.74	-29.43	-26.03
EBIT Margin	-	-	-2273.80%	-2879.16%	-944.21%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.